Mizuho raised the firm’s price target on Herbalife (HLF) to $13 from $11 and keeps a Neutral rating on the shares. The firm adjusted targets in the food producers space as part of its 2026 outlook. Healthy living growth should outperform in 2026, but concerns for competition have compressed valuations, the analyst tells investors in a research note. Mizuho believes weak fundamentals and elevated macro uncertainty “suggest limited prospects for a broad valuation recovery.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF:
